Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 AIDS/HIV. Host controls of HIV neutralizing antibodies.

Literature DB >> 24812389

AIDS/HIV. Host controls of HIV neutralizing antibodies.

Barton F Haynes¹, Laurent Verkoczy.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2014 PMID： 24812389 PMCID： PMC4162091 DOI： 10.1126/science.1254990

Source DB: PubMed Journal: Science ISSN： 0036-8075 Impact factor: 47.728

× No keyword cloud information.

14 in total

1. Crystal structure of a soluble cleaved HIV-1 envelope trimer.

Authors: Jean-Philippe Julien; Albert Cupo; Devin Sok; Robyn L Stanfield; Dmitry Lyumkis; Marc C Deller; Per-Johan Klasse; Dennis R Burton; Rogier W Sanders; John P Moore; Andrew B Ward; Ian A Wilson
Journal: Science Date: 2013-10-31 Impact factor: 47.728

2. Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate.

Authors: F D Batista; M S Neuberger
Journal: Immunity Date: 1998-06 Impact factor: 31.745

3. Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.

Authors: Barton F Haynes; Judith Fleming; E William St Clair; Herman Katinger; Gabriela Stiegler; Renate Kunert; James Robinson; Richard M Scearce; Kelly Plonk; Herman F Staats; Thomas L Ortel; Hua-Xin Liao; S Munir Alam
Journal: Science Date: 2005-04-28 Impact factor: 47.728

4. Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell development.

Authors: E Meffre; M Milili; C Blanco-Betancourt; H Antunes; M C Nussenzweig; C Schiff
Journal: J Clin Invest Date: 2001-09 Impact factor: 14.808

5. Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation.

Authors: Hugo Mouquet; Johannes F Scheid; Markus J Zoller; Michelle Krogsgaard; Rene G Ott; Shetha Shukair; Maxim N Artyomov; John Pietzsch; Mark Connors; Florencia Pereyra; Bruce D Walker; David D Ho; Patrick C Wilson; Michael S Seaman; Herman N Eisen; Arup K Chakraborty; Thomas J Hope; Jeffrey V Ravetch; Hedda Wardemann; Michel C Nussenzweig
Journal: Nature Date: 2010-09-30 Impact factor: 49.962

6. Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance.

Authors: Laurent Verkoczy; Marilyn Diaz; T Matt Holl; Ying-Bin Ouyang; Hilary Bouton-Verville; S Munir Alam; Hua-Xin Liao; Garnett Kelsoe; Barton F Haynes
Journal: Proc Natl Acad Sci U S A Date: 2009-12-14 Impact factor: 11.205

7. B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study.

Authors: Barton F Haynes; Garnett Kelsoe; Stephen C Harrison; Thomas B Kepler
Journal: Nat Biotechnol Date: 2012-05-07 Impact factor: 54.908

Review 8. Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses.

Authors: Dennis R Burton; Pascal Poignard; Robyn L Stanfield; Ian A Wilson
Journal: Science Date: 2012-07-13 Impact factor: 47.728

9. Immune tolerance negatively regulates B cells in knock-in mice expressing broadly neutralizing HIV antibody 4E10.

Authors: Colleen Doyle-Cooper; Krystalyn E Hudson; Anthony B Cooper; Takayuki Ota; Patrick Skog; Phillip E Dawson; Michael B Zwick; William R Schief; Dennis R Burton; David Nemazee
Journal: J Immunol Date: 2013-08-12 Impact factor: 5.422

10. Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies.

Authors: Guang Yang; T Matt Holl; Yang Liu; Yi Li; Xiaozhi Lu; Nathan I Nicely; Thomas B Kepler; S Munir Alam; Hua-Xin Liao; Derek W Cain; Leonard Spicer; John L VandeBerg; Barton F Haynes; Garnett Kelsoe
Journal: J Exp Med Date: 2013-01-28 Impact factor: 14.307

44 in total

1. DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.

Authors: Sachin Gupta; Emily S Clark; James M Termini; Justin Boucher; Saravana Kanagavelu; Celia C LeBranche; Sakhi Abraham; David C Montefiori; Wasif N Khan; Geoffrey W Stone
Journal: J Virol Date: 2015-01-28 Impact factor: 5.103

2. Redemption of autoreactive B cells.

Authors: Barton F Haynes; Laurent Verkoczy; Garnett Kelsoe
Journal: Proc Natl Acad Sci U S A Date: 2014-06-11 Impact factor: 11.205

Review 3. Designing synthetic vaccines for HIV.

Authors: Alberto Fernández-Tejada; Barton F Haynes; Samuel J Danishefsky
Journal: Expert Rev Vaccines Date: 2015-03-31 Impact factor: 5.217

4. Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost.

Authors: Sandrine L Hulot; Bette Korber; Elena E Giorgi; Nathan Vandergrift; Kevin O Saunders; Harikrishnan Balachandran; Linh V Mach; Michelle A Lifton; Giuseppe Pantaleo; Jim Tartaglia; Sanjay Phogat; Bertram Jacobs; Karen Kibler; Beatriz Perdiguero; Carmen E Gomez; Mariano Esteban; Margherita Rosati; Barbara K Felber; George N Pavlakis; Robert Parks; Krissey Lloyd; Laura Sutherland; Richard Scearce; Norman L Letvin; Michael S Seaman; S Munir Alam; David Montefiori; Hua-Xin Liao; Barton F Haynes; Sampa Santra
Journal: J Virol Date: 2015-04-08 Impact factor: 5.103

Review 5. Targeting the N332-supersite of the HIV-1 envelope for vaccine design.

Authors: Thandeka Moyo; Dale Kitchin; Penny L Moore
Journal: Expert Opin Ther Targets Date: 2020-04-27 Impact factor: 6.902

6. The quest for an antibody-based HIV vaccine.

Authors: Barton F Haynes; John R Mascola
Journal: Immunol Rev Date: 2017-01 Impact factor: 12.988

7. HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism.

Authors: Todd Bradley; Guang Yang; Olga Ilkayeva; T Matt Holl; Ruijun Zhang; Jinsong Zhang; Sampa Santra; Christopher B Fox; Steve G Reed; Robert Parks; Cindy M Bowman; Hilary Bouton-Verville; Laura L Sutherland; Richard M Scearce; Nathan Vandergrift; Thomas B Kepler; M Anthony Moody; Hua-Xin Liao; S Munir Alam; Roger McLendon; Jeffrey I Everitt; Christopher B Newgard; Laurent Verkoczy; Garnett Kelsoe; Barton F Haynes
Journal: J Immunol Date: 2016-11-14 Impact factor: 5.422

8. Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site.

Authors: Todd Bradley; Daniela Fera; Jinal Bhiman; Leila Eslamizar; Xiaozhi Lu; Kara Anasti; Ruijung Zhang; Laura L Sutherland; Richard M Scearce; Cindy M Bowman; Christina Stolarchuk; Krissey E Lloyd; Robert Parks; Amanda Eaton; Andrew Foulger; Xiaoyan Nie; Salim S Abdool Karim; Susan Barnett; Garnett Kelsoe; Thomas B Kepler; S Munir Alam; David C Montefiori; M Anthony Moody; Hua-Xin Liao; Lynn Morris; Sampa Santra; Stephen C Harrison; Barton F Haynes
Journal: Cell Rep Date: 2015-12-24 Impact factor: 9.423

9. Analysis of IgM antibody production and repertoire in a mouse model of Sjögren's syndrome.

Authors: Jill M Kramer; Nichol E Holodick; Teresa C Vizconde; Indu Raman; Mei Yan; Quan-Zhen Li; Daniel P Gaile; Thomas L Rothstein
Journal: J Leukoc Biol Date: 2015-09-17 Impact factor: 4.962

10. HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies.

Authors: Wilton B Williams; Hua-Xin Liao; M Anthony Moody; Thomas B Kepler; S Munir Alam; Feng Gao; Kevin Wiehe; Ashley M Trama; Kathryn Jones; Ruijun Zhang; Hongshuo Song; Dawn J Marshall; John F Whitesides; Kaitlin Sawatzki; Axin Hua; Pinghuang Liu; Matthew Z Tay; Kelly E Seaton; Xiaoying Shen; Andrew Foulger; Krissey E Lloyd; Robert Parks; Justin Pollara; Guido Ferrari; Jae-Sung Yu; Nathan Vandergrift; David C Montefiori; Magdalena E Sobieszczyk; Scott Hammer; Shelly Karuna; Peter Gilbert; Doug Grove; Nicole Grunenberg; M Juliana McElrath; John R Mascola; Richard A Koup; Lawrence Corey; Gary J Nabel; Cecilia Morgan; Gavin Churchyard; Janine Maenza; Michael Keefer; Barney S Graham; Lindsey R Baden; Georgia D Tomaras; Barton F Haynes
Journal: Science Date: 2015-07-30 Impact factor: 47.728